Market Report, "Italy Pharmaceuticals & Healthcare Report Q1 2014", Published
The sharp drop in SSN pharmaceutical expenditure in 6M13 cautions that spending on medicines will continue to fall over the rest of the year. This will have an impact on drug companies, pharmacies and patients. Our bearish outlook takes into account the government's aim to slash public healthcare costs. This involved reducing public healthcare costs by EUR900mn (US$1.2bn) in 2012, EUR1.8bn (US$2.4bn) in 2013, EUR2bn (US$2.7bn) in 2014 and EUR2.1bn (US$2.8bn) in 2015.
View full press release